Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients

Gastric cancer (GC) is a typical heterogeneous malignant tumor, whose insensitivity to chemotherapy is a common cause of tumor recurrence and metastasis. There is no doubt regarding the effectiveness of adjuvant chemotherapy (ACT) for GC, but the population for whom it is indicated and the selection...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yin, Xu, Yilun, Li, Yanyan, Chen, Renpin, Cai, Weiyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602567/
https://www.ncbi.nlm.nih.gov/pubmed/34804945
http://dx.doi.org/10.3389/fonc.2021.755271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602567/
https://www.ncbi.nlm.nih.gov/pubmed/34804945
http://dx.doi.org/10.3389/fonc.2021.755271

Ejemplares similares